Cart
sales@molnova.com
MK-0533
CAS No. 668455-28-5
MK-0533( —— )
Catalog No. M36129 CAS No. 668455-28-5
MK-0533 is a novel PPARγ partial agonist for the prevention of vascular endothelial dysfunction (VED) and VED-related cardiovascular disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 219 | In Stock |
|
| 10MG | 326 | In Stock |
|
| 25MG | 523 | In Stock |
|
| 50MG | 737 | In Stock |
|
| 100MG | 1014 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMK-0533
-
NoteResearch use only, not for human use.
-
Brief DescriptionMK-0533 is a novel PPARγ partial agonist for the prevention of vascular endothelial dysfunction (VED) and VED-related cardiovascular disease.
-
DescriptionMK-0533 is a novel PPARγ partial agonist for the prevention of vascular endothelial dysfunction (VED) and VED-related cardiovascular disease.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPPAR
-
RecptorPPAR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number668455-28-5
-
Formula Weight527.49
-
Molecular FormulaC28H24F3NO6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC=1N(C=2C(C1C(=O)C3=CC=C(OC)C=C3)=CC=C(OC(F)(F)F)C2)C4=CC(O[C@@H](C(O)=O)CC)=CC=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
KD-3010
KD-3010 (Kalypsys) is an orally active potent and selective PPARδ agonist for the study of liver injury.
-
(R)-(+)-Bay-K-8644
(R)-(+)-Bay-K-8644 is a Ca2+ channel and dihydropyridine agonist that inhibits Ba2+ currents (IBa), induces central respiratory depression in cats, and inhibits platelet activation through competitive antagonism of thromboxane A2-prostaglandin H2 receptors.
-
Darglitazone
Darglitazone is a potent, selective agonist of PPAR-γ with antidiabetic actions. Darglitazone is effective in controlling blood glucose and lipid metabolism.
